Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Amicus Therapeutics To Announce Full Year 2016 Financial Results And Corporate Updates On March 1 2017 is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, today announced financial results ... Read More
Amicus Therapeutics, Inc. (FOLD)
PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq ... at 8:30 a.m. ET to discuss financial results for the full-year ended December 31, 2023. Participants and ... Read More
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call
March 28, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics ... (OSA in adults)), today announced it plans to release its fourth quarter and full year 2023 financial results after market close today ... Read More
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update
March 28, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics ... for patients with kidney disease, today announced its financial results for the year ended December 31, 2023, and provided a business ... Read More
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
Geneva, Switzerland, April 18, 2024-Addex Therapeutics ... today reported its full-year 2023 financial results for the period ended December 31, 2023 and provided a corporate update. Read More
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
today reported financial results and recent corporate highlights for the year ended December 31, 2023. “We made considerable progress across our pipeline of differentiated neurologic therapies ... Read More
Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates
Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates In ... Alzheimer's disease (AD). In March 2024, Vivoryon announced topline ... Read More
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
PRINCETON, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics ... financial results for the three and twelve months ended December 31, 2023 and provided a corporate update. “2023 was a ... Read More
Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
March 28, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today provided corporate updates and reported its financial ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus